HEMATOPOIESIS AND SERUM IRON CHANGES FOLLOWING VINCRISTINE SULFATE

被引：8
作者：
NESBIT, ME
LOWMAN, JT
机构：
来源：
BLOOD-THE JOURNAL OF HEMATOLOGY | 1969年 / 34卷 / 05期
关键词：
D O I：
10.1182/blood.V34.5.633.633
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：633 / &
相关论文
共 20 条
[1]  
BERTINCHAMPS A, 1958, CANCER, V11, P117, DOI 10.1002/1097-0142(195801/02)11:1<117::AID-CNCR2820110122>3.0.CO
[2]  
2-2
[3]   STUDIES ON ANTIMITOTIC ACTIVITY OF LEUROCRISTINE (VINCRISTINE) [J].
CARDINALI, G ;
ENEIN, MA .
BLOOD, 1963, 21 (01) :102-+
[4]  
CARDINALI GIUSEPPE, 1963, PROC AMER ASSOC CANCER RES, V4, P10
[5]  
HOST H, 1966, SCAND J HAEMATOL, V3, P193
[6]  
ISRAELS LG, 1962, CAN J BIOCHEM PHYS, V40, P667
[7]   MORPHOLOGIC ABNORMALITIES OF BONE MARROW CELLS INDUCED BY CHEMOTHERAPEUTIC AGENTS DURING TREATMENT OF LEUKEMIA [J].
KUNDEL, DW ;
NIES, BA .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1965, 44 (02) :146-&
[8]   REGULATION OF ERYTHROPOIESIS .18. EFFECT OF VINCRISTINE AND ERYTHROPOIETIN ON BONE MARROW [J].
MORSE, BS ;
STOHLMAN, F .
JOURNAL OF CLINICAL INVESTIGATION, 1966, 45 (08) :1241-&
[9]  
NESBIT M, 1968, P AM ASSOC CANC RES, V9, P54
[10]  
NEUSS N., 1964, ADVANCE CHEMOTHERAP, V1, P133
12